Peer-reviewed veterinary case report
A symbiotic filamentous gut fungus ameliorates MASH via a secondary metabolite-CerS6-ceramide axis.
- Journal:
- Science (New York, N.Y.)
- Year:
- 2025
- Authors:
- Zhou, Shuang et al.
- Affiliation:
- Department of Immunology · China
- Species:
- rodent
Abstract
The gut microbiota is known to be associated with a variety of human metabolic diseases, including metabolic dysfunction-associated steatohepatitis (MASH). Fungi are increasingly recognized as important members of this community; however, the role of fungal symbionts in metabolic diseases is unknown. We have systematically isolated and characterized gut fungi, identifyingas an intestinal symbiotic filamentous fungus in mice.reverses MASH progression in mouse models through an intestinal ceramide synthetase 6 (CerS6)-ceramide axis. Moreover, we identified FF-C1, a secondary metabolite from, as a CerS6 inhibitor that has an endogenous protective effect on MASH progression.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/40310917/